Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Settings
Settings
Dynamic quotes
OFFON

school135perm Homepage > Equities > Nyse > Teva Pharmaceutical Industries Limited TEVA

TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVA)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions
Quotes 5-day view Delayed Quote. Delayed Nyse
01/08/2018 01/09/2018 01/10/2018 01/11/2018 01/12/2018 Date
19.12(c) 19.37(c) 20.04(c) 21.74(c) 22.07(c) Last
12 056 428 19 476 176 32 640 576 35 280 893 40 511 401 Volume
-0.52% +1.31% +3.46% +8.48% +1.52% Change
More quotes
Financials ($)
Sales 2017 22 633 M
EBIT 2017 6 276 M
Net income 2017 -
Debt 2017 34 419 M
Yield 2017 -
Sales 2018 20 650 M
EBIT 2018 5 056 M
Net income 2018 -
Debt 2018 27 811 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018
EV / Sales2017 2,50x
EV / Sales2018 2,42x
Capitalization 22 178 M
More Financials
Company
Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company, which provides patient-centric healthcare solutions.It operates through two segments: Generic Medicines and Specialty Medicines.The Generic Medicines segment includes chemical and therapeutic equivalents of originator medicines...
Sector
Pharmaceuticals
Calendar
02/08Earnings Release
More about the company
Latest news on TEVA PHARMACEUTICAL INDUST
02:02pTEVA PHARMACEUTICAL INDUSTRIES : Announces U.S. FDA Approval of TRISENOX® (arsen..
01/14TEVA PHARMACEUTICAL INDUSTRIES : Moody's cuts Teva debt to junk status
01/12TEVA PHARMACEUTICAL INDUSTRIES : Ohio Talks Settlement Of Opioid Lawsuits -- WSJ
01/11JOHNSON & JOHNSON : Ohio Takes Steps Toward Resolution of Opioid Litigation
01/11TEVA PHARMACEUTICAL INDUSTRIES : Analysts regain confidence in Teva
01/11JOHNSON & JOHNSON : Ohio in Talks to Settle Opioid Suit, State Attorney General ..
01/10HISTADRUT CHIEF : Teva is spitting in Israel's face
01/10TEVA PHARMACEUTICAL INDUSTRIES : board of directors takes 50% pay cut
01/10TEVA PHARM DIRECTORS CUT THEIR SALAR : board member
01/10TEVA PHARMACEUTICAL INDUSTRIES : Pharm directors cut their salaries in half - bo..
More news
Sector news : Pharmaceuticals - NEC
05:26pDrugmaker Dermapharm gears up for likely first German IPO of 2018
01/12Drugmakers see a pricing blueprint in an $850,000 gene therapy
01/12SPARK'S PRICE FOR LUXTURNA BLINDNESS : Icer
01/12ASTRAZENECA : Receives FDA Approval for Breast Cancer Treatment
01/12WPP Buys London-based Mash Strategy
More sector news : Pharmaceuticals - NEC
Chart TEVA PHARMACEUTICAL INDUST
Duration : Period :
Teva Pharmaceutical Indust Technical Analysis Chart | TEVA | US8816242098 | school135perm
Income Statement Evolution
Consensus
Mean consensus OUTPERFORM
Number of Analysts 2
Average target price 23,3 $
Spread / Average Target 6,7%
Managers
NameTitle
Kåre Schultz President, Chief Executive Officer & Director
Sol J. Barer Chairman
Carlo de Notaristefani President & CEO-Global Operations
Michael McClellan Chief Financial Officer & Executive Vice President
Amir Elstein Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
TEVA PHARMACEUTICAL INDUSTRIES LIMITED16.46%21 401
JOHNSON & JOHNSON4.32%388 981
NOVARTIS1.80%224 968
PFIZER0.88%217 923
ROCHE HOLDING LTD.-0.28%217 905
MERCK AND COMPANY4.25%159 987
Copyright © 2018 Surperformance. All rights reserved.